Navigation Links
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
Date:5/16/2012

ND with R256.

ATS Poster Presentations
A Randomized, Placebo Controlled Trial of the Effect of an Inhaled SYK Inhibitor on Allergen Induced Airways Responses in Mild Asthma (R343)
May 21, 2012, 8:15AM – 4:30PM
Poster Session: B33 – ASTHMA THERAPY: NOVEL APPROACHES

Janus Kinase (JAK) 3 Inhibitor, R256, Attenuates Allergen-Induced Airway Hyperresponsiveness and Airway Inflammation in Mice
May 21, 2012, 8:15AM – 4:30PM
Poster Session: B33 – ASTHMA THERAPY: NOVEL APPROACHES

R256 Is a Potent and Selective IL13/4 Receptor Signaling Inhibitor That Reduces Inflammation In a Mouse Model of Chronic Asthma
May 21, 2012, 8:15AM – 4:30PM
Poster Session: B37 – NEW INSIGHTS INTO ASTHMA AND COPD TREATMENT

About Rigel (www.rigel.com)
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with our partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's future product candidate pipeline and strategy.  Any statements contained in this pres
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... from a new PET trial showing that the Cefaly ... the brain in migraine patients, namely the orbitofrontal cortex ... (PET) scan, which is an imaging test of the brain, used a ...
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
(Date:6/1/2015)... Unlike most generator rental companies, which raise their rates ... to when the generator is in standby mode, WPP charges ... generator or not. WPP also offers an offsite storage option ... a few hours — for companies that do not have ... , “Even minor business disruptions are very expensive for commercial ...
(Date:6/1/2015)... June 01, 2015 Rio Salado College’s ... children and young adults this summer. , The clinics take ... a.m. to 3 p.m. at the Rio Salado Dental Clinic. ... Tempe. , “A big goal for us is to offer ... for our students,” said Nikki Shipp, Clinical Coordinator for Rio’s ...
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
(Date:6/1/2015)... 01, 2015 KC and Monica Craichy, ... of the best superfood products in the ... in Texas. , "Monica and I are excited ... in distributing Living Fuel Super Meals - SuperBerry®, SuperGreens ... floods in Texas," KC Craichy said. "We have attempted ...
(Date:6/1/2015)... 01, 2015 Northridge dentist , ... offering patients a promotion on Invisalign for a limited ... treatment is reduced to $3,700. Patients can find out ... consultation and discuss the extent of correction they need. ... be combined with any other offer. , Invisalign ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Kids Receive Complimentary Dental Services at Rio Salado Dental Clinic 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2
... PAUL, Minn., July 3 The Minnesota Nurses,Association (MNA) ... for U.S. House of Representatives, Congressional District 2., ... will be the vigorous and,informed advocate we need in ... said MNA Political Committee Chair, Tom Kelly, RN.,"With his ...
... Previous measures aimed at adults, but Australian team says these ... -- A series of tests that are the first to ... developed by Australian researchers. , Using these three tests ... the Odor Identification Test -- the researchers determined that most ...
... National and regional healthcare,leaders will convene in Mendocino ... Improve Patient Care in 2008.", "Ultimately we want ... electronic medical record software and by enabling the exchange,of ... president of Redwood MedNet, the conference host., The ...
... of disease in developing countries, study suggests, , , THURSDAY, ... where breast-feeding is a necessity, and HIV is rampant, ... be reduced if infants were first fed a freeze-dried ... potentially destroy the deadly virus. , But that hope ...
... in a historical,and unprecedented move, the Pennsylvania legislature ... 1150 to mandate commercial,insurance companies to cover some ... House Speaker Dennis M. O,Brien, requires insurance,companies to ... less than 21 years old., In nearly ...
... July 3 Dangerous air pollution,resulting from wildfires ... in the surrounding areas. Residents with respiratory problems ... with chronic heart,disease should take extra precautions during ... develop., "Even those without lung diseases are ...
Cached Medicine News:Health News:Minnesota Nurses Association Endorses Steve Sarvi for Congress 2Health News:Improving Healthcare in Rural Northern California Goal of One-Day Conference of National and State Healthcare Leaders 2Health News:Freeze-Dried Formula May Block HIV Virus in Breast Milk 2Health News:Pennsylvania Tells Autism Speaks to Stop Talking 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 3
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscopes....
... ,Launched in 1988, this design revolutionized ... standard practice in general anesthesia. Used successfully ... Classic™ is a safe hands free alternative ... Classic™ can be used for a wide ...
Medicine Products: